Your browser is no longer supported. Please, upgrade your browser.
PFE Pfizer Inc. daily Stock Chart
Pfizer Inc.
IndexDJIA S&P500 P/E30.05 EPS (ttm)1.13 Insider Own0.04% Shs Outstand6.07B Perf Week-1.14%
Market Cap205.44B Forward P/E12.80 EPS next Y2.65 Insider Trans-31.04% Shs Float6.06B Perf Month-2.67%
Income6.99B PEG4.61 EPS next Q0.62 Inst Own71.90% Short Float0.65% Perf Quarter-3.99%
Sales52.29B P/S3.93 EPS this Y-21.50% Inst Trans-3.06% Short Ratio2.06 Perf Half Y12.17%
Book/sh10.34 P/B3.28 EPS next Y7.56% ROA4.20% Target Price39.47 Perf Year10.19%
Cash/sh3.45 P/C9.81 EPS next 5Y6.52% ROE10.90% 52W Range27.77 - 37.08 Perf YTD7.82%
Dividend1.20 P/FCF33.96 EPS past 5Y1.60% ROI7.30% 52W High-8.66% Beta0.86
Dividend %3.54% Quick Ratio1.10 Sales past 5Y-5.60% Gross Margin77.80% 52W Low21.97% ATR0.49
Employees97900 Current Ratio1.40 Sales Q/Q-42.10% Oper. Margin17.60% RSI (14)44.91 Volatility1.61% 1.34%
OptionableYes Debt/Eq0.70 EPS Q/Q-58.80% Profit Margin13.40% Rel Volume1.49 Prev Close33.32
ShortableYes LT Debt/Eq0.49 EarningsNov 01 BMO Payout101.70% Avg Volume19.17M Price33.87
Recom2.20 SMA20-0.90% SMA50-3.09% SMA2003.89% Volume28,533,241 Change1.65%
Jun-20-16Reiterated Jefferies Buy $42 → $40
May-12-16Initiated Berenberg Hold $38
May-04-16Reiterated UBS Buy $36 → $38
Apr-18-16Resumed Goldman Neutral $35
Apr-07-16Resumed Morgan Stanley Equal-Weight $35
Apr-07-16Resumed JP Morgan Overweight $38
Nov-25-15Upgrade Sun Trust Rbsn Humphrey Reduce → Neutral
Nov-03-15Reiterated Argus Buy $41 → $46
Oct-28-15Reiterated Deutsche Bank Buy $41 → $43
Oct-02-15Upgrade Morgan Stanley Equal-Weight → Overweight $35 → $38
Jul-29-15Reiterated Argus Buy $39 → $41
Jun-17-15Initiated Piper Jaffray Overweight
Apr-30-15Reiterated Argus Buy $36 → $39
Apr-29-15Downgrade Citigroup Buy → Neutral
Jan-28-15Reiterated Argus Buy $35 → $36
Dec-18-14Reiterated Deutsche Bank Buy $34 → $35
Jul-02-13Downgrade Standpoint Research Hold → Sell $24
Apr-15-13Reiterated Barclays Equal Weight $25 → $32
Jan-30-13Reiterated UBS Buy $29 → $31
Jan-30-13Reiterated Argus Buy $28 → $32
Sep-30-16 07:24PM  US Market Indexes Gain on Friday
02:45PM  3 Top Healthcare Stocks to Buy Now at Motley Fool
01:25PM  The Highest-Yielding Drug Stocks at Motley Fool
12:56PM  Kite, Anavex, G.W. Pharma Help Revive Biotech Sector Chemistry
11:05AM  Which Pfizer Products Reported Declining Sales?
10:05AM  Which Products Were Key Contributors to Pfizers Revenue Growth?
08:06AM  Pfizers Innovative Health and Essential Health Businesses
Sep-29-16 06:59PM  Deutsche Bank's Losses Affecting the Market on Thursday
06:04PM  The Pfizer-Anacor Deal: A Review
05:20PM  Why Exelixis, Inc. Continued Its Downfall Today at Motley Fool
05:04PM  A Look at the Pfizer-Medivation Deal
04:23PM  U.S. Stocks Sell Off On Deutsche Bank Worries, But Oil Plays Surge
04:03PM  Troubles for Deutsche Bank, Wells Fargo Drag Down Wall Street
04:01PM  Goldman, Merck Lead DJIA Thursday Plunge
02:42PM  How Does Pfizers Valuation Compare?
10:03AM  7 Healthcare Stocks in Focus on World Heart Day
09:07AM  How Oncology Could Move the Needle for Johnson & Johnson's Stock at Motley Fool
08:45AM  Trade extends bearish position in Pfizer
Sep-28-16 11:43AM  Why Oracle, SolarCity, Tesla and Two Other Stocks Are Making Headlines Today at Insider Monkey
10:05AM  Teva Is Well Placed to Dominate the European Generics Market
09:29AM  Battle of the Pharmaceutical Bigwigs: GlaxoSmithKline vs. Pfizer
08:50AM  Pfizer Completes Acquisition of Medivation Business Wire
08:06AM  Teva Pharmaceutical Still Dominates the Generic Market in Europe
07:51AM  Today's Top 5 Stock Picks: Pfizer, Apple, GE, More at
06:00AM  Pfizer to Showcase Progress of Broad-Based Oncology Portfolio at European Society for Medical Oncology (ESMO) 2016 Congress Business Wire
Sep-27-16 06:10PM  Teva Is Well Positioned for New Trends in the US Generic Market
04:21PM  Opko Health Has Big News on Deck at Motley Fool
02:12PM  Markets In Monotone Mode Despite Post-Debate Rally
12:22PM  What Gives With Biosimilars? at Motley Fool
12:06PM  Eli Lilly Stock Upgraded: What You Need to Know at Motley Fool
11:05AM  Pharmaceuticals Deal with End of Key Cystic Fibrosis Study
10:44AM  Pfizer (PFE) to Stay Together as a Single Company After All
10:04AM  This Strategy Could Boost Tevas Growth Prospects Even More
09:49AM  Is This Pfizer's Next Mega-Blockbuster Cancer Drug? at Motley Fool
09:15AM  Blog Coverage US Pharma Giant Pfizer to Whole as one Complete Unit Accesswire
09:12AM  Blog Coverage US Pharma Giant Pfizer to Whole as one Complete Unit
08:06AM  Pfizer's Latest Immunotherapy Deal Could Be Great News for This Tiny Company at Motley Fool
07:40AM  Major Pharma Continues to See Rising Tide in Short Interest at 24/7 Wall St.
06:59AM  [$$] Pfizer Throws Out Plan to Split Into Two Companies at The Wall Street Journal
12:59AM  PRESS DIGEST - Wall Street Journal - Sept 27 Reuters
Sep-26-16 09:37PM  [$$] Overheard at The Wall Street Journal
07:23PM  Presidential Debate a Factor for the Market This Week
06:05PM  [$$] Pfizer Won't Split and Neither Should Investors at
06:00PM  How the Dow Jones industrial average fared on Monday
05:57PM  Business Highlights
04:32PM  US STOCKS-Wall St drops as investors brace for presidential debate
04:32PM  Regeneron-Sanofi Could Beat Pfizer, Roche, AstraZeneca On Eczema
04:30PM  Unexpected Twist: Pfizer Scraps Breakup Following Dead Allergen Merger
04:03PM  Wall Street Sells Off on Worries Over Clinton-Trump Showdown
04:01PM  Goldman Sachs, JPMorgan Sink DJIA Monday at 24/7 Wall St.
03:12PM  Drugmaker Pfizer decides not to break up business
02:51PM  Pfizer decides against split-up; more deals seen likely
02:48PM  These Investors Are Glad Pfizer Has Decided Not to Split at
02:46PM  For Pfizer, Bigger as One May Be Better Than Smaller With Two at Bloomberg
02:43PM  US STOCKS-Wall St falls as investors brace for presidential debate
02:38PM  Stocks Fall Ahead of Clinton-Trump Debate, Crude Rallies
01:44PM  US STOCKS-Pfizer, banks lead Wall St lower; presidential debate eyed
01:08PM  Wyeth -- Moody's affirms Pfizer's ratings; changes outlook to stable at Moody's
12:17PM  Read Scraps Pfizer Break-up As Megadeals Escape Its Grasp
12:08PM  [$$] Pfizer drops plans to split into essential and innovative units at Financial Times
12:05PM  Stocks Open Week On Down Note; Acacia Slumps On Offering, Outlook
11:57AM  Pfizer (PFE) Stock Declines, Bernstein: More Deals Seem Likely
11:47AM  Pfizer abandons plan to split into two companies
11:35AM  [$$] Pfizer Throws Out Plan to Split Into Two Companies at The Wall Street Journal
11:24AM  Pfizer: Split Decision at
11:22AM  Pfizer Can Conquer by Not Dividing at Bloomberg
11:20AM  US STOCKS-Wall St drops as Pfizer falls; presidential debate eyed
11:20AM  Stocks Fall as Health Care Slumps Ahead of Presidential Debate
11:10AM  Pfizer Decides Against the Split
11:05AM  Winning? We Review How Teva Dominates Generic Drug Space
11:05AM  A Look at Johnson & Johnsons Recent Stock Performance
11:05AM  How Mylans Profitability Has Changed
10:52AM  Pfizer Decides Not to Split Business at TheStreet
10:28AM  Why Pfizer, Netflix,, Deutsche Bank, and Cal-Maine Foods Are Trending at Insider Monkey
10:05AM  US STOCKS-Wall St drops as Pfizer falls, Deutsche Bank drags financials
09:20AM  Stocks to Watch: Chemtura, Deutsche Bank, Array BioPharma at The Wall Street Journal
09:03AM  US STOCKS-Wall St set to open lower as presidential debate looms
08:23AM  Stock Futures Fall With Clinton-Trump Showdown Looming
08:05AM  Pfizer (PFE) Stock Falls, Ends Plan to Split Into Two Companies
07:02AM  Pfizer says not to split into two
06:59AM  Pfizer decides against splitting into two companies at MarketWatch
06:58AM  Pfizer Wont Split, Ending Years of Speculation About Drug Giant at Bloomberg
06:58AM  Pfizer Wont Split, Ending Years of Speculation About Drug Giant
06:50AM  Pfizer Wont Pursue Splitting in Two Separate Units at Bloomberg
06:45AM  Pfizer Decides Remaining One Company Best Positions Company To Maximize Future Value Creation Business Wire
Sep-25-16 01:04PM  Dont fire until you see the whites of their eyes
Sep-23-16 07:04PM  Generics or Specialty: Which Mylan Segment Is Growing Fastest?
05:25PM  Tevas Valuation Multiples Compared to Other Generic Drug Players
04:17PM  The 5 Highest Dividend Payout Ratios on the Dow at Motley Fool
04:07PM  Axovant Confidence 'Not Swayed' After Rival Alzheimer's Drug Fails
02:12PM  Dow 30 Stock Roundup: Microsoft Rewards Shareholders; GE Wins $1.9B Nuclear Power Contract
10:01AM  Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study
09:28AM  [video]Takeover Chatter Around Clovis May Be Overdone
08:30AM  Pfizer Announces Expiration of HSR Waiting Period For Proposed Acquisition of Medivation Business Wire
08:03AM  Better Buy: Pfizer Inc. vs. Johnson & Johnson at Motley Fool
08:00AM  Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO
07:29AM  UPDATE 1-Novartis's Zykadia gets positive results, faces Roche pressure Reuters
Sep-22-16 01:43PM  Lundbeck says Alzheimer's late-stage study fails Reuters
11:56AM  Pfizer Declares 30-Cent Fourth-Quarter 2016 Dividend Business Wire
Sep-21-16 04:32PM  'Blockbuster Franchises' Spark M&A Fever For Sarepta, Ariad, Biotechs
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops and commercializes medicines for various therapeutic areas, including inflammation/immunology, cardiovascular/metabolic, neuroscience/pain, and rare diseases. The VOC segment develops and commercializes vaccines, as well as products for oncology and consumer healthcare. It provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H brands; and respiratory and personal care products under the brand names of Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp, and ChapStick. The GEP segment offers products that have lost marketing exclusivity in various markets; and branded generics, generic sterile injectable products, biosimilars, infusion systems, and other products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has licensing agreements with Cellectis SA and AstraZeneca PLC; and collaborative agreements with Eli Lilly & Company, OPKO Health, Inc., BioRap Technologies LTD., and Merck KGaA. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMELIO FRANK AExecutive Vice PresidentMay 26Option Exercise24.43100,0002,443,000472,994May 27 11:03 AM
DAMELIO FRANK AExecutive Vice PresidentMay 26Sale34.49100,0003,449,115372,994May 27 11:03 AM
CANGIALOSI LORETTA VSr. Vice President, ControllerMay 24Option Exercise25.8786,0002,224,820271,663May 26 10:07 AM
CANGIALOSI LORETTA VSr. Vice President, ControllerMay 24Sale33.9786,0002,921,147185,663May 26 10:07 AM
YOUNG JOHN DGroup PresidentMay 10Option Exercise25.8741,7001,078,779200,399May 11 06:04 PM
DAMELIO FRANK AExecutive Vice PresidentMay 10Option Exercise24.43192,0004,690,560564,994May 11 06:04 PM
YOUNG JOHN DGroup PresidentMay 10Sale33.5341,7001,398,277158,699May 11 06:04 PM
DAMELIO FRANK AExecutive Vice PresidentMay 10Sale33.66192,0006,462,579372,994May 11 06:04 PM
READ IAN CChairman & CEOMay 09Option Exercise25.74275,0007,078,2501,471,738May 11 06:03 PM
SUSMAN SALLYExecutive Vice PresidentMay 09Option Exercise22.2823,884532,136199,735May 11 04:35 PM
HILL CHARLES HExecutive Vice PresidentMay 09Sale33.8429,6001,001,65160,828May 11 04:35 PM
SUSMAN SALLYExecutive Vice PresidentMay 09Sale33.7167,8842,288,669131,851May 11 04:35 PM
READ IAN CChairman & CEOMay 09Sale33.80275,0009,295,0391,196,738May 11 06:03 PM
SUSMAN SALLYExecutive Vice PresidentMay 05Option Exercise22.2856,0161,248,036231,867May 06 09:51 AM
SUSMAN SALLYExecutive Vice PresidentMay 05Sale33.7156,0161,888,144175,851May 06 09:51 AM
SUSMAN SALLYExecutive Vice PresidentMay 04Option Exercise22.2820,100447,828195,951May 06 09:51 AM
SUSMAN SALLYExecutive Vice PresidentMay 04Sale33.8720,100680,762175,851May 06 09:51 AM
DAMELIO FRANK AExecutive Vice PresidentMay 03Sale33.6587,0792,930,208372,994May 05 05:27 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 24Option Exercise18.90110,9812,097,541274,756Feb 26 03:05 PM
MADDALUNA ANTHONY JExecutive Vice PresidentFeb 24Option Exercise18.9062,4531,180,362140,772Feb 26 03:05 PM
OLSON LAURIE JExecutive Vice PresidentFeb 24Option Exercise18.9018,984358,79889,467Feb 26 03:05 PM
READ IAN CChairman & CEOFeb 24Option Exercise18.90584,11211,039,7172,030,151Feb 26 03:05 PM
SUSMAN SALLYExecutive Vice PresidentFeb 24Option Exercise18.90110,9812,097,541263,151Feb 26 03:05 PM
YOUNG JOHN DGroup PresidentFeb 24Option Exercise18.9052,570993,573188,679Feb 26 03:05 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 24Option Exercise18.9034,171645,832210,943Feb 26 03:05 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 24Option Exercise18.90210,2803,974,292622,467Feb 26 03:05 PM
Dolsten MikaelPresident R&DFeb 24Option Exercise18.90210,2803,974,292577,902Feb 26 03:05 PM
HILL CHARLES HExecutive Vice PresidentFeb 24Option Exercise18.9078,8551,490,360149,135Feb 26 03:05 PM
JOHNSON RADY AExecutive Vice PresidentFeb 24Option Exercise18.9019,188362,65366,048Feb 26 03:05 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 24Option Exercise18.9034,171645,832149,482Feb 26 03:05 PM
BOURLA ALBERTGroup PresidentFeb 24Option Exercise18.9030,666579,587144,675Feb 26 03:03 PM
BOURLA ALBERTGroup PresidentDec 15Option Exercise26.2030,000786,000140,560Dec 16 06:46 PM
YOUNG JOHN DGroup PresidentDec 14Option Exercise26.2031,500825,300163,999Dec 16 06:55 PM
PFIZER INC10% OwnerOct 06Buy7.00714,2854,999,9952,253,509Oct 07 05:42 PM